These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31577594)
1. Impact of the microbiota on solid organ transplant rejection. Sepulveda M; Pirozzolo I; Alegre ML Curr Opin Organ Transplant; 2019 Dec; 24(6):679-686. PubMed ID: 31577594 [TBL] [Abstract][Full Text] [Related]
2. Influence of the microbiome on solid organ transplant survival. Pirozzolo I; Li Z; Sepulveda M; Alegre ML J Heart Lung Transplant; 2021 Aug; 40(8):745-753. PubMed ID: 34030971 [TBL] [Abstract][Full Text] [Related]
3. Gut microbes contribute to variation in solid organ transplant outcomes in mice. McIntosh CM; Chen L; Shaiber A; Eren AM; Alegre ML Microbiome; 2018 May; 6(1):96. PubMed ID: 29793539 [TBL] [Abstract][Full Text] [Related]
4. Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance. Jardou M; Brossier C; Marquet P; Picard N; Druilhe A; Lawson R Front Cell Infect Microbiol; 2024; 14():1342354. PubMed ID: 38476165 [TBL] [Abstract][Full Text] [Related]
5. The Microbiome, Systemic Immune Function, and Allotransplantation. Nellore A; Fishman JA Clin Microbiol Rev; 2016 Jan; 29(1):191-9. PubMed ID: 26656674 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and renal transplant outcome. Ardalan M; Vahed SZ Biomed Pharmacother; 2017 Jun; 90():229-236. PubMed ID: 28363168 [TBL] [Abstract][Full Text] [Related]
8. The composition of the microbiota modulates allograft rejection. Lei YM; Chen L; Wang Y; Stefka AT; Molinero LL; Theriault B; Aquino-Michaels K; Sivan AS; Nagler CR; Gajewski TF; Chong AS; Bartman C; Alegre ML J Clin Invest; 2016 Jul; 126(7):2736-44. PubMed ID: 27322054 [TBL] [Abstract][Full Text] [Related]
9. Revisiting the liver's role in transplant alloimmunity. Abrol N; Jadlowiec CC; Taner T World J Gastroenterol; 2019 Jul; 25(25):3123-3135. PubMed ID: 31333306 [TBL] [Abstract][Full Text] [Related]
10. Gender issues in solid organ donation and transplantation. Ge F; Huang T; Yuan S; Zhou Y; Gong W Ann Transplant; 2013 Sep; 18():508-14. PubMed ID: 24064859 [TBL] [Abstract][Full Text] [Related]
11. Chronic rejection as a persisting phantom menace in organ transplantation: a new hope in the microbiota? Mongodin EF; Saxena V; Iyyathurai J; Lakhan R; Ma B; Silverman E; Lee ZL; Bromberg JS Curr Opin Organ Transplant; 2021 Dec; 26(6):567-581. PubMed ID: 34714788 [TBL] [Abstract][Full Text] [Related]
12. New directions for induction immunosuppression strategy in solid organ transplantation. Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743 [TBL] [Abstract][Full Text] [Related]
13. Immunologic Effects of the Microbiota in Organ Transplantation. Rey K; Choy JC Clin Lab Med; 2019 Mar; 39(1):185-195. PubMed ID: 30709506 [TBL] [Abstract][Full Text] [Related]
14. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Duncan MD; Wilkes DS Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of immune monitoring in solid organ transplantation. Daniel V; Opelz G Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320 [TBL] [Abstract][Full Text] [Related]
16. Cytokine-targeted therapy for the management of solid organ transplant recipients. Szczepanik A; Iasella CJ; McDyer JF; Ensor CR Hum Immunol; 2019 Mar; 80(3):184-190. PubMed ID: 30562564 [TBL] [Abstract][Full Text] [Related]
17. Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients. Geissler EK; Hutchinson JA Curr Opin Organ Transplant; 2013 Aug; 18(4):408-15. PubMed ID: 23838645 [TBL] [Abstract][Full Text] [Related]
19. Why do we need biomarkers in solid organ transplantation. Olbricht CJ Clin Chim Acta; 2012 Sep; 413(17-18):1310-1. PubMed ID: 22562075 [TBL] [Abstract][Full Text] [Related]
20. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P; Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]